Presentation is loading. Please wait.

Presentation is loading. Please wait.

Analysis of Donor Factors for Non–Heart-Beating Donors With Regard to Cadaveric Kidney Transplantation in the Western Region of Japan  N. Nakamura, M.

Published byJodie Pearson Modified over 6 years ago

Similar presentations

Presentation on theme: "Analysis of Donor Factors for Non–Heart-Beating Donors With Regard to Cadaveric Kidney Transplantation in the Western Region of Japan  N. Nakamura, M."— Presentation transcript:

1 Analysis of Donor Factors for Non–Heart-Beating Donors With Regard to Cadaveric Kidney Transplantation in the Western Region of Japan  N. Nakamura, M. Tanaka, M. Tsukamoto, Y. Shimano, M. Yasuhira, J. Ashikari  Transplantation Proceedings  Volume 49, Issue 1, Pages (January 2017) DOI: /j.transproceed Copyright © 2016 Elsevier Inc. Terms and Conditions

2 Fig 1 Annual change of the number of organ donations.
Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

3 Fig 2 Patients and graft survival (N = 589).
Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

4 Fig 3 Age distribution of non–heart-beating donors (N = 304).
Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

5 Fig 4 Analysis of graft survival categorized by donor age (N = 589).
Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

6 Fig 5 Analysis of graft survival stratified by donor age (under 70 vs over 70) (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

7 Fig 6 Cause of death in non–heart-beating donors (N = 304).
Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

8 Fig 7 Graft survival of analysis stratified by cause of death (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

9 Fig 8 Graft survival of analysis stratified by cause of death (cardiovascular disease vs other diseases) (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

10 Fig 9 Graft survival of analysis stratified by cause of death (atherosclerotic disease vs other disease) (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

11 Fig 10 Graft survival of analysis stratified by final serum creatinine before donation (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

12 Fig 11 Graft survival of analysis stratified by duration of anuria (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

13 Fig 12 Graft survival of analysis stratified by presence of cannulation (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

14 Fig 13 Graft survival of analysis stratified by WIT (N = 589).
Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

15 Fig 14 Graft survival of analysis stratified by WIT (WIT under 30 minutes vs over 30 minutes) (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

16 Fig 15 Graft survival of analysis stratified by TIT (TIT under 24 hours vs over 24 hours) (N = 589). Transplantation Proceedings  , 16-25DOI: ( /j.transproceed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

Download ppt "Analysis of Donor Factors for Non–Heart-Beating Donors With Regard to Cadaveric Kidney Transplantation in the Western Region of Japan  N. Nakamura, M."

Similar presentations

1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 4.1 Chapter 4.

1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 4.1 Chapter 4.
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages 20-44 (January 2014) DOI: 10.1016/j.cell.2013.12.012.

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: 10.1016/j.trre.2012.07.003.

ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Leading Efforts to Increase Organ Donation Through Professionalization of Organ Procurement Organizations and Establishment of Organ and Tissue Donor Registries.

Leading Efforts to Increase Organ Donation Through Professionalization of Organ Procurement Organizations and Establishment of Organ and Tissue Donor Registries.
Endovascular Treatment of Vertebral Artery Stenosis

Endovascular Treatment of Vertebral Artery Stenosis
Organ Trafficking: Global Solutions for a Global Problem

Organ Trafficking: Global Solutions for a Global Problem
Effect of Verapamil and Lidocaine on TRPM and NaV1

Effect of Verapamil and Lidocaine on TRPM and NaV1
Quantifying Mesenchymal Stem Cells in the Mononuclear Cell Fraction of Bone Marrow Samples Obtained for Cell Therapy  M. Alvarez-Viejo, Y. Menendez-Menendez,

Quantifying Mesenchymal Stem Cells in the Mononuclear Cell Fraction of Bone Marrow Samples Obtained for Cell Therapy  M. Alvarez-Viejo, Y. Menendez-Menendez,
Donor age still matters in liver transplantation

Donor age still matters in liver transplantation
Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45:107-114 - DOI:10.1159/000453047.

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Volume 57, Issue 5, Pages (May 2000)

Volume 57, Issue 5, Pages (May 2000)
Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis

Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis
Renal Function Testing

Renal Function Testing
Diagnosis and Management of Chronic Kidney Disease

Diagnosis and Management of Chronic Kidney Disease
Colin R. Lenihan, MB, BCh, BAO, Jane C. Tan, MD, PhD 

Colin R. Lenihan, MB, BCh, BAO, Jane C. Tan, MD, PhD 
Outcomes of cardiac surgery in chronic kidney disease

Outcomes of cardiac surgery in chronic kidney disease
Are patients willing to travel for better ovarian cancer care?

Are patients willing to travel for better ovarian cancer care?
Living donor liver transplantation: is the hype over?

Living donor liver transplantation: is the hype over?

Similar presentations

Ads by Google